Clinical experience with a novel endotoxin adsorbtion device in patients undergoing cardiac surgery

Perfusion

Volumn 24, Issue 1, 2009, Pages 13-17

  Blomquist, Sten ^a   Gustafsson, V ^a   Manolopoulos, T ^a   Pierre, L ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adsorbtion; Cardiopulmonary bypass; Endotoxin; Inflammatory mediators

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; COMPLEMENT; LIPOPOLYSACCHARIDE;

ADSORPTION; ADULT; AGED; AORTA CLAMPING; ARTICLE; BLOOD CLOT; BLOOD CLOTTING; BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; DEVICE; ENDOTOXEMIA; EXTRACORPOREAL CIRCULATION; FLOW RATE; HEART SURGERY; HEART VALVE SURGERY; HUMAN; PERFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SAFETY; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; TOXIN ANALYSIS; BLOOD; CLINICAL TRIAL; EQUIPMENT DESIGN; INSTRUMENTATION; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED;

ADSORPTION; ADULT; AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; COMPLEMENT SYSTEM PROTEINS; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MIDDLE AGED; PLATELET COUNT; THROMBELASTOGRAPHY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349229430     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659109106730     Document Type: Article

References (14)

1. Chenoweth, DE, Cooper, SW, Hugli, T, Stewart, R, Blackstone, E, Kirklin, J. Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylotaxins. N Engl J Med 1981; 304(9): 497-503.
2. Kirklin, JK, Westaby, S, Blackstone, EH, Kirklin, JW, Chenoweth, DE, Pacifico, AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86(6): 845-857.
3. Butler, J, Rocker, GM, Westaby, S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-559.
4. Baldwin, WM 3rd, Pruitt, SK, Brauer, RB, Daha, MR, Sanfilippo, F. Complement in organ transplantation. Contributions to inflammation, injury, and rejection. Transplantation 1995; 59(6): 797-808.
5. Bhole, D, Stahl, GL. Therapeutic potential of targeting the complement cascade in critical care medicine. Crit Care Med 2003; 31(1): S97-S104.
6. Dong, J, Pratt, JR, Smith, RA, Dodd, I, Sacks, SH. Strategies for targeting complement inhibitors in ischaemia/reperfusion injury. Mol Immunol 1999; 36: 957-963.
7. Danner, RL, Elin, RJ, Hosseini, JM, Wesley, RA, Reilly, JM, Parillo, JE. Endotoxin in human septic shock. Chest 1991; 99: 169-175.
8. Venkatamaran, R, Subramanian, S, Kellum, JA. Clinical review: extracorporeal blood purification in severe sepsis. Critical Care 2003; 7: 139-145.
9. Shoji, H. Extracorporeal endotoxin removal for the treatment of sepsis. Endotoxin adsorbtion cartridge (Toramycin). Ther Apher&Dial 2003; 7: 108-114.
10. Vincent, J-L, Laterre, P-F, Cohen, J, et al. A pilotcontrolled study of a polymyxin B immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra abdominal infection. Shock 2005; 23: 400-405.
11. Levy, JH, Tanaka, KA. Inflammatory response to cardiopulmonary bypass. Ann Thor Surg 2003; 75: S175.
12. Ohki, S, Oshima, K. Takeyoshi, I, et al. Endotoxin removal with a polymyxin B-immobilized hemoperfusion cartridge improves cardiopulmonary function after cardiopulmonary bypass. J Surg Res 2008; 145: 74-79.
13. Kulabukhov, VV. Use of an endotoxin adsorber in the treatment of severe abdominal sepsis. Acta Anaesthesiol. Scand 2008; 57: 1024-1025.
14. Kojika, M, Sato, N, Yaegashi, Y, et al. Endotoxin adsorbtion therapy for septic shock using polymyxin B-immobilized fibers (PMX). Evaluation by highsensitivity endotoxin assay and measuremet of the cytokine production capacity. Ther Apher Dial 2006; 10: 12-18.